Log inSign up
Naveen Pemmaraju, MD
22.5K posts
user avatar
Naveen Pemmaraju, MD
@doctorpemm
Professor, Leukemia; Executive Director-Cancer Medicine for MDACC Cancer Network | Director #BPDCN Program | Co-Section Head, MPN #MPNSM ;Tweets:my own opinions
Houston, TX
faculty.mdanderson.org/Naveen_Pemmara…
Joined April 2014
2,881
Following
20.6K
Followers
  • Pinned
    user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Feb 12
    👉👉👉Delighted to share our brand new paper 📝 now online @JCO_ASCO | Final results of our Ph 1/2 #Pivekimab Sunirine (#CD123-targeted ADC) in patients with #BPDCN | ascopubs.org/doi/full/10.12… | led by @doctorpemm & @Daver_Leukemia | @MDAndersonnews #endcancer #BPDCN #leusm
    Image
    28K
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Sep 1, 2023
    👉👉👉Deeply honored to share that I have been Promoted to Professor of Leukemia starting today! 🙏 @MDAndersonNews🙏 to all who supported me on this journey. I dedicate this honor to our patients&their families w/#RareDisease #endcancer #BPDCN #leusm #MPNSM #TeamPemm #ProfPemm
    Image
    77K
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Apr 21, 2022
    Proud to share that, in addition to my current duties, I have been named as the Cancer Network Director for Leukemia for the MD Anderson Cancer Network! Looking forward to serving @MDAndersonNews in this new role. @mpdrc @mekupferman @michael_overman @VivekSubbiah @DrHKantarjian
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Sep 5, 2020
    👉Proud to share my new designation as Director, Blastic Plasmacytoid Dendritic Cell Neoplasm (#BPDCN) Program in @LeukemiaMDA || Thank you 🙏 to my mentors&dept leadership Dr Kantarjian & Dr Konopleva for their guidance&support || mdanderson.org/research/depar… | #leusm #RareDisease
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Apr 3, 2023
    👉👉👉Deeply honored to be awarded the @MDAndersonNews Faculty Educator of the Year Award 🥇!!🙏🏾 to my mentors @DrHKantarjian Dr @mkonople @Transplant_Doc @GBorthakur & Dr Neelapu for support & 🙏🏾 all of my mentees! This means the 🌍 to me!🙏🏾 Dr @DianeBodurka&Dr Chambers&team!
    Image
    30K
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Dec 10, 2022
    #ASH22 Honored to be named an #MPNHero at this evening’s super inspiring event at @WWIImuseum @cure_today Awards Ceremony & even more overjoyed to be able to share this lovely honor with my family here in #NOLA for this all-time special evening !!!! Thank you !❤️❤️ ❤️ 🙏🏾👏🏽
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Dec 12, 2020
    Delighted to share that I was honored to receive the Gerald P. Bodey for Excellence in #Education @MDAndersonNews Award yesterday! 🙏 to all of my colleagues, team members, #mentors & #mentees for your faith in me & this highest honor! #endcancer #MPNSM #BPDCN #leusm #meded
    Image
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Apr 4, 2020
    Day 4 Leukemia Rounds. #SaturdayAMRounds | Long & lonely are the days during #COVID19 era. No matter. I will keep coming to work to keep our patients safe&healthy. If you don’t need to be out please #StayHomeStaySafe #WashYourHands #SocialDistancing b/c #WeAreAllInThisTogether
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Apr 25, 2019
    👉👉👉Hot off the presses Our group’s new paper just out in ⁦@NEJM⁩ !! ➡️ #Tagraxofusp (SL-401) in Blastic Plasmacytoid Dendritic-Cell Neoplasm | #BPDCN | ⁦@lane_andy⁩ ⁦@DrHKantarjian⁩ Konopleva ⁦@LeukemiaMDA⁩ ⁦@DanaFarber⁩
    Image
    nejm.org
    Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm | NEJM
    Blastic plasmacytoid dendritic-cell neoplasm (BPDCN) is an aggressive hematologic cancer that is caused by transformed plasmacytoid dendritic cells that overexpress interleukin-3 receptor subunit a...
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Oct 26, 2020
    It’s my birthday 🎂 today! For my birthday, my only wish is to wish each of you to have peace, health, security, a chance to VOTE 🗳, time with family, meaning, and to give yourself some space for grace. #meded #BPDCN #leusm #bmtsm #MPNSM || #WeAreAllInThisTogether #endcancer
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Feb 19, 2022
    👉👉👉Delighted to share our group’s new paper now online in @JCO_ASCO led by @harrisoncn1 & @doctorpemm 🙌 Ph2 #Navitoclax + #Ruxolitinib in patients with Myelofibrosis || ascopubs.org/doi/pdf/10.120… || @mpdrc @pankitvachhani @Ramikomrokji @sk_tantravahi #BCLxL #MPNSM
    Image
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Jan 8, 2022
    Sending a huge shout out & heartfelt thank you 🙏🏾 to the brilliant Dr. Tatiana Prowell .@tmprowell for keeping us safe & informed;for her altruism,essential posts,teaching & truth-telling during these unprecedented pandemic times. #OslerPride #COVID19 🙏🏾
    Image
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Jun 3, 2023
    #ASCO23 Congratulations to our Leukemia Chair Professor Dr @DrHKantarjian upon being awarded the David Karnofsky Award 🥇 @ASCO || @MDAndersonNews #endcancer #leusm #Leadership #CancerResearch 🙌
    Image
    13K
  • user avatar
    Naveen Pemmaraju, MD
    @doctorpemm
    Aug 31, 2024
    👉Superb review article by Prof .@NitinJainMD et al on CLL in the @TheLancet Aug 2024 Chronic lymphocytic leukaemia - The Lancet thelancet.com/journals/lance… | #leusm #endcancer @wwierda @MDAndersonnews @HemeReports
    Image
    15K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement